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Abstract 
Objectives. As the psychostimulant effects of amphetamines have been implicated in the 
sensitization of sexual behavior, this study examined if the injection of amphetamines predicted 
heterosexual sex risk behavior among people who injected drugs (PWIDs) in Central and Eastern 
Europe who were, predominantly, opiate injectors. HIV serostatus and other STI diagnoses were 
also examined as potential covariates of amphetamine injection predicting sex risk. Furthermore, 
the effect of established syringe exchange programs (SEPs) on the relationship between 
amphetamine injection and sex risk in the region of Central Europe and Ukraine was compared 
to that of recently initiated SEPs in the Russian Federation.  Method.  PWIDs (N=1671) were 
randomly recruited at SEPs in ten cities of Central and Eastern Europe in 1999 and 2000, for 
confidential interviews about their drug use and HIV-related injection and sex risk behavior. 
Results. Results of multivariate logistic regressions indicated that the injection of amphetamines 
predicted heterosexual sex risk in the Russian Federation with two types of sex partners: (1) 
primary partners (OR=1.6; 95% CI=1.0, 2.5; p=.04); and (2) casual partners (OR=2.3; 95% CI= 
1.2, 4.4; p=.01). Age was a marginally significant covariate of amphetamine injection predicting 
sex risk among Russian PWIDs and their primary partners (OR=1.032; CI=1.002, 1.063; p=.04), 
indicating a marginal increase in sex risk among those who were older. Amphetamine injection 
was not significantly related to heterosexual sex risk in Central Europe and Ukraine.  HIV 
serostatus and history of STIs were not significantly associated with amphetamine injection to 
predict sex risk in either region.  No significant relationship was found between number of 
months participating at SEPs and sex risk among amphetamine injectors.  Conclusions. 
Amphetamine injection amplified heterosexual sex risk in the Russian Federation but did not in 
Central Europe and Ukraine. Further investigation of findings of this study that suggest a 
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subculture of preferential amphetamine injectors in the Russian Federation could illuminate the 
regional differences in heterosexual sex risk among amphetamine injectors.   
Amphetamines, sexual risk behavior, injecting drug use, HIV, Central and Eastern Europe 
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 Injection of Amphetamines, Heterosexual Sex Risk, and Syringe Exchange  
in Central and Eastern Europe 
Amphetamine Use in Central and Eastern Europe 
The illicit use of amphetamines in Central and Eastern Europe has been based in a 
convention of home-made drug production. Limited data exist about stimulant use patterns in 
those regions (Des Jarlais et al., 2002; Grund, Zabransky, Irwin & Heimer, 2010).  However, 
research about amphetamine use in Central and Eastern Europe indicates that illicit 
amphetamines had been commonly derived from non-prescription products and black market 
prescription medications containing ephedrine or pseudoephedrine since the 1980’s (Grund et al., 
2010; Pinkham, 2010). Recipes for amphetamine-type stimulants utilized in those areas have 
generally differed between those that call for the reduction of (pseudo-)ephedrine to produce 
methamphetamine and those that call for the oxidization of (pseudo-)ephedrine to produce 
methcathinone (Grund et al., 2010).  Both analogs may be produced in crystal, powder or liquid 
form.  Information about some black marketing of amphetamines in the 1990’s was reported by 
syringe exchange programs (SEPs) in the Czech Republic, Hungary and Poland (Ban, 1993; 
Sananim, 1998; Wodowski & Zygadlo, 1997).  In the Czech Republic, where methamphetamine 
was a major drug of choice and ecstasy had newly appeared on the black market, the marketing 
of amphetamines was described as moderate: 
“The marke[t] was supplied with pills and volatile crude opium and home made drugs 
mainly codeine derivate and amphetamine … there wasn’t a real market because drug users were 
a closed group, making, changing and using drugs within themselves (Sananim, 1998).” 
 The popularity of the production of home-made amphetamines in Central and Eastern 
Europe for injection purposes has been particularly relevant to the spread of HIV. Their use may 
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also have physical consequences that amplify the risk of sexual transmission of HIV by drying 
mucous membranes in the vagina and rectum, decreasing membrane sensitivity and increasing 
the risk of torn membranes and infection during penetrative sex (Reference Group to the United 
Nations on HIV and Injecting Drug Use, 2007). Indeed, complex psychophysical effects of 
amphetamine use (Hoffman et al., 2007) include important implications for the interrelationship 
of amphetamine injection and HIV-related sexual risk. 
Amphetamines and Sexual Behavior 
The psychostimulant effects of amphetamine and its analogs have been implicated in the 
sensitization of sexual behavior (Fiorino & Phillips, 1999; Hoffman et al., 2007; Leigh, Ames & 
Stacy, 2008).  The relationship between amphetamine use and sexual behavior, although not 
thoroughly understood, comprises neurophysiological and environmental components.  
Amphetamines are psychoactive substances that lower brain stimulation reward thresholds 
(Hyman, 2005; Nestler, Hyman & Malenka, 2009).  They are addictive, positively reinforcing 
stimuli and can be associated with behaviors and places that increase the probability of their 
repeated use (Corsi & Booth, 2008; Nestler et al., 2009; Theall, Elifson & Sterk, 2006).     
Amphetamines potentiate monoamine transmission in the brain (Moore, 1977).  They 
disrupt vesicular storage of dopamine, norepinephrine and serotonin in nerve terminals, resulting 
in increased monoamine release (Erickson, 2007; Nestler et al., 2009).  Psychostimulant impact 
on the dopaminergic system projects from the ventral tegmental area of the midbrain along brain 
reward pathways to the nucleus acumbens and other forebrain structures (Nestler et al., 2009) 
that regulate cognitive functions and behavioral control (Fillmore, 2003).  In healthy adults, low 
doses of d-amphetamine have improved behavior control by reducing inhibition response time on 
tasks requiring response suppression (de Wit, Enggasser & Richards, 2002).  On the other hand, 
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both long-term and high-dose amphetamine use have produced neurological maladaptations that 
impaired behavior control, i.e., caused sensitization and amplified disinhibition, exhibited as 
impulsiveness and chronic, stereotyped behavior (Fillmore, 2003; Hoffman et al., 2007; Hyman, 
2005; McKim, 2007; Moore, 1977).    
Some animal studies of amphetamine injection indicated that amphetamine use 
augmented appetitive and consummatory sexual behavior.  Sexually naïve male rats treated with 
a series of injections of d-amphetamine exhibited greater mounting and intromitting behaviors 
than controls that were injected with saline, independent of the environment in which the 
treatment had occurred (Fiorino & Phillips, 1999).  Both sexually experienced and sexually naïve 
female rats were treated with a series of injections of d-amphetamine and subsequently exhibited 
more solicitations, hops and darts, and female-male mounting behaviors than controls that were 
injected with saline whether or not the treatment was paired with the testing environment 
(Afonso, Mueller, Stewart, &  Pfaus, 2009).  Male rats that were treated with ecstasy ( (+) 3,4 
methylenedioxymeth-amphetamine, MDMA), an amphetamine derivative, exhibited more 
erections and ejaculations when sleep-deprived than male rats that were treated with cocaine 
(Anderson et al., 2006).   
Subjective reports of human subjects about the potency of the effects of amphetamine use 
differ according to the mode of administration and amphetamine type. When injected or smoked, 
people have reported that they experience an intense rush of pleasurable feeling.  When snorted 
or ingested, the experience is reportedly less intense, yet, still euphoric (Drug Enforcement 
Administration, U.S. Department of Justice, 2009). The acute effects of methamphetamine can 
last more than 24 hours, potentially causing more impact on the central nervous system than 
other amphetamines.  The effects of methcathinone have been described as comparable 
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(Hoffman et al., 2007); although more euphoric (Pinkham, 2010), less potent, and less popular 
than the effects of methamphetamine use (Grund et al., 2010). The knowledge of chemistry and 
the skill of producers of home-made amphetamines also contribute to the effects of amphetamine 
use among drug networks that consume home-made substances (Grund et al., 2010). 
Additionally, personality factors, such as novelty and sensation seeking, have been associated 
with greater subjective and psychophysiological responsiveness to the stimulant effects of 
amphetamine use (Hutchison, Wood & Swift, 1999). 
Increased arousal, including sexual arousal, confidence and attentiveness; and fatigue and 
suppressed appetite are commonly experienced with the use of amphetamines (McKim, 2007; 
Nestler, 2009; National Institute on Drug Abuse, National Institutes of Health, Department of 
Health and Human Services, 2005).  Human subjects research has linked amphetamine, 
methamphetamine, methcathinone and MDMA use with increased sexual desire and drive as 
well as sensation seeking and sexual risk (Bang-Ping, 2009; Celentano et al., 2008; Corsi & 
Booth, 2008; Grund et al., 2010; Leigh et al., 2008; Molitor, Truax, Ruiz, & Sun, 1998; Ross & 
Williams, 2001; Theall et al., 2006).  Sexual risk behaviors — neglecting to use a condom when 
having sex or having multiple or indiscriminate sex partners — may develop as external 
expressions of impaired inhibition and “cross-sensitization” (Fiorino & Phillips, 1999) that are 
induced by increased amphetamine use and unconsciously facilitate sexual desire and sensation 
seeking. 
Injecting Drug Use, Sex Risk and HIV in Central and Eastern Europe 
This study examined the impact of the injection of amphetamines on the sexual risk 
behavior of people who injected drugs (PWIDs) at high risk for HIV infection in Central and 
Eastern Europe. The data for this study come from a secondary dataset of PWIDs who 
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participated in SEPs in ten Central and Eastern European cities in 1999 and 2000 and reported 
recent heterosexual sex behavior (Des Jarlais et al., 2002).   Injection of homemade opiates or 
imported powder heroin predominated in the sample.  However, patterns of drug use varied and 
substantial injection of powder and self-made liquid amphetamines was reported across the 
PWID enclaves that were represented. 
The interrelationship of injecting drug use and sexual risk behavior in the development of 
the HIV epidemic in Central and Eastern Europe has been documented.  In Eastern Europe, an 
upsurge of already epidemic injecting drug use and corresponding unsafe injection practices 
(Grund et al., 2010; Kelly & Amirkhanian, 2003; EuroHIV 2003; Lancet (the leading edge) 
2003; UNAIDS/WHO 2002) accounted for 60% of HIV incidence from 1996 to 2001 (Hamers & 
Downs, 2003).  In the same period, injecting drug use accounted for the second largest 
proportion (28%) of HIV incidence in Central Europe; where the source of infection of the 
largest proportion (47%) of new cases remained unreported through 2001 and men who had sex 
with men accounted for 10% of new cases (Hamers & Downs, 2003).    
Prior to this study, reports of sexual risk-taking among PWIDs in the two regions 
established that PWID risk was compounded by inconsistent condom use and multiple sex 
partners. More than three-quarters (77%) of 611 drug users participating at a SEP in Prague, 
Czech Republic reported having sex without a condom over a recent six-month period; and the 
proportion of those not using condoms increased as the number of their sexual partners increased 
(Mikl et al., 1998). A survey among 239 PWIDs in St. Petersburg, Russia who were 14–25 years 
old found within the most recent 30 days that 41% of the participants shared needles, 36% had 
multiple sex partners and 70% of the sexually active had engaged in vaginal sex without using 
condoms (Somlai et al., 2002). Sexual risk among PWIDs also posed a risk among their non-
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injecting sex partners, particularly in Eastern Europe, where the epidemic advanced 
heterosexually and among women beyond communities of PWIDs (UNAIDS, 2002).   An 
assessment of HIV testing in a rural oblast1 of the Russian Federation found that half (49%) of 
the patients who had been infected with HIV via heterosexual sex had sexual contact with 
PWIDs (Molotilov et al., 2003).  PWIDs who traded in sex were a special public health concern. 
Reportedly 10% to 88% of sex workers in cities across Ukraine and the Russian Federation 
injected drugs (Atlani, Carael, Brunet, Frasca, & Chaika, 2000; Protopopov et al., 2000; Rhodes, 
Sarang, Bobrik, Bobkov, & Platt, 2004). Sex work placed PWIDs and their clients at an elevated 
risk for infection with HIV and other sexually transmitted infections (STIs) (Kacena et al., 2001; 
Protopopov, Martynova & Kolesnikova, 2000) in increasingly STI-endemic areas (Aral, 2001; 
Waugh, 1999). Their clients could be local or, like truckers who sought sex workers along 
highway strolls, could be passing through, potentially carrying infections to other locations.   
Prompted by research findings that different types of sexual relationships were associated with 
different levels of risk, this study differentiated sex risk among primary, casual and sex work 
partners of its participants as well as investigated the potential co-morbidity of self-reported HIV 
incidence and history of STIs among them.   
Regional differences in sexual risk behavior.  Regional differences in exposure to 
syringe exchange services and subsequent impact on sexual risk among amphetamine injectors 
were also examined.  Central European and Ukrainian participants in this study utilized SEPs 
that had been in operation for several years (Table 1).  On the other hand, four of five SEPs in 
the Russian Federation that were utilized by study participants were new the year that interviews 
for this study took place (Table 2).  In 2000, Cox, Lawless, Cassin and Geoghegan found no 
change in reported levels of condom use among PWIDs in the first three months of their 
                                                 
1 Oblast: the largest governmental subdivision within countries that were formerly republics of the U.S.S.R. 
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utilization of SEP services. Quite differently, more recent research followed PWIDs’ utilization 
of syringe exchange services over a more extended period of time and found that unprotected 
vaginal intercourse among them was reduced by 26% after three years (Huo & Ouellet, 2009). 
This study therefore also investigated if amphetamine injectors at SEPs in five cities of Central 




 Participants of this study were randomly recruited to be interviewed among PWIDs who 
utilized syringe exchange at SEPs in ten Central and Eastern European cities. They were 
recruited by locally hired, independent interviewers who had been trained in research methods 
for the study. A goal of 2250 interviews was set, consisting of: 
1. 200 interviews per SEP in the five cities of Prague, the Czech 
Republic; Budapest, Hungary; Skopje, FYR Macedonia; Krakow, 
Poland; and Poltava, Ukraine; and 
2. 250 interviews per SEP in the five Russian cities of Nizhniy-
Novgorod, Pskov, Rostov-na-Donu, St. Petersburg and Volgograd. 
Some events occurred prior to and during data collection that impeded fulfillment of the 
original data collection goals at each of the SEPs. Arsonists destroyed the bus that served as the 
mobile SEP unit in St. Petersburg early in the project year, disabling full operations for most of 
the year.  Drug user “round-up” campaigns by police and drug-dealer territorial conflicts 
terrorized drug users in Krakow. SEP participants’ distrust of strangers in Krakow was 
aggravated. To bridge the distrust, SEP staff were permitted to conduct research interviews in 
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Krakow and subsequently 91 participants were interviewed there. The resignation of the director 
of the SEP in Budapest disrupted SEP management and operations and consequently only 73 
participants were interviewed there.   
Getting the project up and running in Russia was an extended process overall that delayed 
the initiation of Russian data collection until December, the last month of the project year.  
Although Russian data collection was extended through the following January, was well 
organized and generally successful, the constraints of time and rough, winter weather were 
challenging and Russian data collection fell somewhat short of its goals.   
Taking into account the elimination of 60 duplicate interviews collected across the ten 
SEPs, the total number of participants came to 1955. For purposes of consensus across the ten 
SEPs, only interviews of participants who provided data for both “30 days prior” to participation 
in syringe exchange and “in the past 30 days” of SEP participation were used in data analysis. 
The resulting sample (N=1671) comprises 74% of all participants of the study sample.  
Syringe Exchange Programs. The selection of ten SEPs for this study was made among 
Central and Eastern European SEPs that were funded by the International Harm Reduction 
Development Program of the Open Society Institute (IHRD/OSI).2  IHRD/OSI participated in the 
selection, guided by its interest to determine the success of a diverse group of SEPs to reduce 
risk of infection with HIV in injecting-drug-use endemic locations. Computer, electronic mail 
and photocopier/printing capacities of each SEP were assessed to assure communications with 
the research team and to confirm the SEPs’ abilities to print study instruments or to have them 
printed. SEP locations, membership sizes, current and projected patterns of syringe exchange and 
the starting dates of new SEPs were considered in order to estimate the total number of 
                                                 
2 OSI is a private, philanthropic foundation that funds human rights programs and initiatives around the world. IHRD is an OSI 
public health initiative focused “on diminishing the individual and social harms associated with drug use.” (Open 
Society Foundations 2011). 
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interviews that might be completed within the project year.  Central European and Ukrainian 
SEPs had been in operation from two to four years (Table 1). The three-year-old SEP in St. 
Petersburg with an established client base was selected as a counterweight of SEP participation 
experience to the choice of four, new SEPs in other Russian cities that were about to initiate their 
enrollment process (Table 2).   
Project coordination of the five Central European and Ukrainian SEPs was done from 
New York City. Therefore, English-speaking study contacts among the SEP staff of all five 
Central European and Ukrainian cities were appointed. Coordination of the study in Russia was 
two-tiered. An English-speaking Russian partner was appointed in Moscow to supervise the 
study at the five Russian SEPs in coordination with the New York City research team.  
Procedures and Materials 
An informed consent statement and interview instrument were first developed in English 
by the research team and then translated by a professional translation company in New York City 
into the languages that were spoken at the locations of the SEPs: 
1. Prague: Czech 
2. Budapest: Hungarian 
3. Skopje: Macedonian 
4. Krakow: Polish 
5. Poltava: Ukrainian; Russian 
6. Nizhny-Novgorod, Pskov, Rostov-na-Donu, St. Petersburg and Volgograd:  Russian 
Each translation was additionally critiqued by harm reduction educator experts to include drug-
user terminology that was commonly used in the different cities and regions of the study.  
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Independent interviewers were hired in each of the cities in the study and were trained by 
the research team to conduct data collection at nine of the ten SEPs. SEP staff were trained to 
interview participants in Krakow because the staff of the SEP was firmly convinced that 
participants would not trust non-staff to interview them. Potential bias of the self-reports of the 
Krakow participants will be considered in the discussion of the results. 
A random sampling method was used to recruit participants for the survey.  Interviewers 
utilized a random-number (n) chart to approach each nth SEP participant who was witnessed 
exchanging syringes at SEP exchange sites. SEP participants typically formed short lines at the 
sites of exchanges, so a random-number chart based on the numbers one through five was used 
to optimize recruitment results.  As a result, the likelihood of sampling frequent exchangers was 
also increased (Des Jarlais et al., 2002). 
All data collection was conducted in a face-to-face and confidential manner as was 
determined appropriate for vulnerable populations. No personal information was requested that 
would allow individual identification of the participants.  Before conducting every interview, an 
informed consent statement was read aloud to each participant and participants provided verbal 
informed consents only. All interview data were individual, self-reports.  All interviews were 
conducted at syringe exchange sites or nearby locations, as was required for adequate privacy 
and, in the case of outdoor sites of exchange, as was dictated by the weather.  All responses to 
interview questions were noted by hand on hard-copy, paper questionnaires by the individual 
interviewers.  
At the beginning of each interview, participants at nine of the ten SEPs generated unique 
ten-character ID codes based on a formula developed for the study to distinguish their 
interviews. Participant ID codes consisted of the first three letters of the first name of the 
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participant’s mother; a two-digit day of the participant’s birth; the first three letters of the 
participant’s first name; and a two-digit month of the participant’s birth.  Budapest participants 
were reportedly resistant to revealing information to generate the study ID code and were 
permitted to use their established SEP membership codes, instead.  
Interviews were approximately 45 minutes in length. Each participant received a small 
gift or cash valued at US$1-3 immediately upon completing an interview. SEP staff had been 
consulted to determine what types of reimbursements were appropriate for each location. 
Measures 
The interview instrument included questions about demographics; experience with the 
criminal justice system; types of drug use (in the 30 days prior to participation at the SEP; and in 
the most recent 30 days); injection risk behaviors (in the 30 days prior to participation at the 
SEP; and in the most recent 30 days); penetrative sex and sexual risk behaviors (in the most 
recent 30 days); testing, status and treatment of HIV, STIs and other illnesses for which PWIDs 
were particularly at risk; AIDS knowledge; and experience with each city’s social services 
system.  Questions about penetrative sex and sexual risk behaviors applied to any penetrative 
sex, site of penetration unspecified, with partners of the same and opposite sex who were 
primary, casual or sex work partners for money or drugs. Questions about kinds of drugs used 
and references to methods of drug manufacture and administration were adapted to the cultural 
practices of the sample in consultation with IHRD/OSI staff that mentored the SEPs participating 
in the study. To permit quantitative statistical analysis of the total sample as a whole, responses 
were either categorical, multiple-choice items that were coded numerically or were continuous 
variables. 
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For purposes of testing the impact of amphetamine injection on sexual risk behaviors, the 
following subset of variables was investigated: 
1. frequency of amphetamine injection in the past 30 days of SEP participation; 
participants could choose one of ten ranked responses within a range of “never” to 
“10 or more times a day almost every day;” 
2. frequency of penetrative sex in the past 30 days of SEP participation with 
opposite-sex  primary partners, casual partners, sex work partners who gave 
money for sex and sex work partners who gave drugs for sex; participants could 
choose one of ten ranked responses within a range of “never” to “10 or more 
times a day almost every day;” 
3. sexual risk behaviors in the past 30 days of SEP participation measured as the 
proportion of the times participants used condoms when having sex with each 
type of partner of the opposite sex; participants could choose one of five ranked 
responses within a range of “never” to “always;” any response less than “always” 
was defined as sexual risk; 
4. current HIV serostatus, if known; and 
5. ever having been diagnosed with other STIs that included syphilis, gonorrhea, 
chlamydia and pelvic inflammatory disease. 
 
Although interview questions addressed penetrative sex and sexual risk behavior with 
partners of the same sex and partners of the opposite sex, only 23 (1%) of participants reported 
any sex with the same sex, precluding valid statistical tests of same sex data.  As a result, this 
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study specifically investigated the relationship between amphetamine injection and heterosexual 
sex risk.  
Data preparation and corrections.  The preparation of data for statistical analysis for 
this study required a number of corrections.  Central European and Ukrainian data were sent by 
each of the SEPs to the New York office for cleaning.  Data collected in cities of the Russian 
Federation were cleaned at the office of the Russian partner.  As a result, types of errors detected 
in Central European and Ukrainian data varied among those cities; whereas a single coding 
discrepancy detected in Russian data was consistent across those cities and was most likely the 
result of a recoding decision made by that office.  
Some individual interviewers in Prague, Budapest, Skopje and Krakow did not follow 
skip instructions properly when asking questions about sexual risk behavior.  Consequently, 18 
participants who reported having no penetrative sex in exchange for drugs in the past 30 days 
also responded to questions about consistency of condom use with partners who gave drugs for 
sex in the past 30 days. Left uncorrected, this series of errors would increase the frequency of 
sexual risk behavior with partners who gave drugs for sex by 60%.  The findings of univariate 
logistic regression tests for sexual risk with partners who gave drugs for sex among amphetamine 
injectors were insignificant for both uncorrected and corrected data.  As a result, findings in this 
paper for this type of sex risk reflect tests of those data after being corrected.  Responses about 
sexual risk with partners who gave drugs for sex among participants who first reported no sex 
with that type of partner were redefined as missing.  The same pattern of skip errors occurred 
among data about sex risk with primary partners, casual partners and partners who gave money 
for sex to much less extent.  As those errors comprised no more than 1% of the totals for each of 
those types of sex risk, the findings reported in this paper are of those data after being corrected.  
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Interviewer skip errors also produced discrepancies among reports of number of 
participants who had HIV tests, number of participants who received HIV test results and 
number of participants who received positive HIV test results.  In Prague, Skopje, Krakow and 
Poltava, a sum of 24 more participants reported test results than reported tests.  Responses given 
about test results were redefined as missing for those participants who reported no past HIV tests 
and never receiving HIV test results.  HIV prevalence in Krakow and in Poltava was reduced by 
1% in each city after data were corrected.  The findings about HIV serostatus in this paper are 
based on the analysis of the corrected data.   
Some data from the cities of the Russian Federation and from Krakow and Poltava about 
the frequency of use of different types of drugs in the past 30 days were not coded according to 
the coding system designed for the study. As the estimated difference caused by the error was 
less than 5%, results of this analysis are based on corrections of those errors.  
Redefinition of variables. Data preparation also included the redefinition of variables.  
Because variables about types of amphetamine use differentiated them as “powder” and “self-
made, liquid” but did not differentiate them chemically (for example, methamphetamine vs. 
methcathinone), different variables of amphetamine use were summed as one variable so that the 
investigation of “amphetamine injection” was undifferentiated by type. As well, amphetamine 
injectors were a minority among the total sample.  The numbers of amphetamine injectors in the 
individual cities of the study were too small for comparative analyses among the cities. Two 
general strategies were applied that maximized options for effective logistic regression.  First, 
tests of the impact of amphetamine injection on sexual risk behaviors were limited to the total 
sample (N=1671) and to two geographical regions represented by the locations of data 
collection: 
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1. Central Europe and Ukraine (N= 595): Prague, Budapest, Skopje, Krakow and 
Poltava; and 
2. Russia (N=1076): Nizhny-Novgorod, Pskov, Rostov-na-Donu, St. Petersburg 
and Volgograd. 
Second, as categorical variables used in this study were ordinal and included a zero point, 
they were converted into dichotomous variables.   
As a result, sex risk was defined as “did not always use a condom” when having 
penetrative sex.  Safe sex was defined as “always used a condom” when having penetrative sex.   
As data were insufficient for testing individual variables of syphilis, gonorrhea, 
chlamydia and pelvic inflammatory disease, these variables were combined to create one general 
variable of the prevalence of sexually transmitted infections (STIs). 
For purposes of capturing the diversity of opiates that were injected in one variable, 
different variables of opiate injection (heroin powder, homemade opiates and opium) were 
combined to create one general variable of the prevalence of “opiates” injection. 
Data Analysis 
The t-test procedure was used to evaluate if mean age differed significantly between the 
two regions of the study. The chi-square test was used to assess if proportions varied 
significantly in bivariate analyses of gender, diagnostic test results, injection of amphetamines 
and injection of opiates, and penetrative sex among amphetamine injectors.  Logistic regression 
was used to test if amphetamine injection was significantly related to sexual risk, when 
controlling for effects of age and gender; and if history of STIs or self-reported HIV serostatus 
were significant covariates of amphetamine injection predicting sexual risk.  Analysis of 
variance tests were made to test if the number of months of participation at SEPs was 
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significantly related to sex risk among amphetamine injectors. Only test values with an alpha 
value below .05 were considered statistically significant.  
Results 
Demographics and Health  
 Table 3.  Participants in the Russian Federation were younger (p<.0001) and more likely 
to be HIV positive (p=.01) than those in Central Europe and Ukraine. 
 In both regions, participants were predominantly in their twenties (overall M=25.9; 
SD=6.3).  More than three quarters of the participants were male (77% overall).  In light of their 
general youthfulness, reports of sexually transmitted infections by a quarter of each regional 
sample (24% overall) were grounds for intensified public health concern (Waugh, 1999), 
potentially compounding participants’ risk for HIV infection.  Reports of past HIV tests were 
equally and generally common in the regions (79% overall).  HIV+ test results were twice as 
common (p=.01) in the Russian Federation (11%) as in Central Europe and Ukraine (6%).    
Amphetamine Injection among Opiate Injectors 
Table 4. As identified in an earlier study of the injection risk behaviors of this sample, 
the variability of patterns of drug use among the different cities otherwise precluded 
generalizations about the sample as a whole (Des Jarlais et al., 2002).  Therefore, findings here 
compare regional patterns of amphetamine injection among opiate injectors encountered in the 
drug user communities in this study within which sexual risk has been examined. Amphetamine 
injection in the past 30 days was significantly more common (p=.005) in Central Europe and 
Ukraine (25%) than in the Russian Federation (19%).  Although opiate injection predominated at 
similar rates in both regions (87%-90%), half as many amphetamine injectors (p<.0001) in the 
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Russian Federation (41%) reported injecting opiates as did those in Central Europe and Ukraine 
(83%), suggesting a subculture of preferential amphetamine injectors in the Russian Federation.  
Heterosexual Patterns of Penetrative Sex 
 Table 5. Penetrative heterosexual sex reported by amphetamine injectors reflected 
regional differences of the sample as a whole.  The occurrence of heterosexual sex reported by 
PWIDs in the Russian Federation (78%) as well as those among them who injected 
amphetamines (79%) was greater (p<.0001) than that of PWIDs in Central Europe and Ukraine 
(57%) and amphetamine injectors there (60%).  
Amphetamine Injection and Heterosexual Sex Risk  
Tables 6 – 8. Regardless of age, gender, history of STIs and HIV serostatus, 
amphetamine injection did not predict heterosexual sex risk in the five cities of Central Europe 
and Ukraine.  Being male when controlling for age and gender (p=.03)  and additionally 
controlling for STIs (p=.02) was significantly associated with sex risk with casual partners in that 
region, however, suggesting that the gender of Central European and Ukrainian participants 
predicted sex risk with casual partners independent of the type of drug that was injected. 
Tables 9 – 11. In comparison, when controlling for age and gender, findings in the five 
cities of the Russian Federation indicated that amphetamine injection predicted heterosexual sex 
risk with (1) primary partners (OR=1.6; 95% CI=1.0, 2.5; p=.04); and (2) casual partners 
(OR=2.3; 95% CI= 1.2, 4.4; p=.01).  Age was a marginally significant modifier of the effect of 
amphetamine injection on sex risk with primary partners (OR=1.032; CI=1.002, 1.063; p=.04), 
indicating a marginally increased probability of sex risk among older amphetamine injectors.  
HIV status and history of STIs did not significantly modify the effect of amphetamine injection 
on heterosexual sex risk in the Russian Federation.  However, those who reported that they were 
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HIV+ were significantly more likely to have safe sex with their primary partners (p<.0001) than 
those who were HIV–, suggesting the possibility that knowledge that one were HIV+ may have 
been a mitigating factor of sex risk dependent on type of sex partner. 
Impact of SEP Participation on Heterosexual Sex Risk 
Table 12.  In order to illuminate regional differences in the research findings about 
amphetamine injection and heterosexual sex risk, differences in the number of months that 
amphetamine injectors participated at SEPs were compared to determine if the duration of SEP 
membership was associated with a reduction of sexual risk behavior in different types of sexual 
relationships.  No significant associations were found.  
Discussion 
 The findings of this study confirm that the injection of amphetamines significantly 
predicted heterosexual sex risk among PWIDs who participated in syringe exchange in the 
Russian Federation with their primary and non-commercial, casual sex partners.  
No findings differentiated between amphetamine injection and heterosexual sex risk 
behaviors among participants who traded sex for money or for drugs.  The numbers of 
participants who reported trading sex were usually low, or were too low to permit meaningful 
analysis. The extra stigma associated with the trade may have inhibited disclosure or 
participation in the study.  Sex workers may also have visited the SEPs less frequently than other 
participants, limiting opportunities for interviewers to recruit them for the study.  Sex workers 
were among the most impoverished in their communities and the demands of working on night 
strolls, sometimes along highways on the fringe of their cities, and maintaining their drug habits 
could have made SEP participation prohibitive.  Notably, most reports of sex work by this 
sample were by participants in Ukraine and Russia, indicating the reach of syringe exchange to 
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areas where a synergistic impact of injecting drug use and sex work on the spread of STIs had 
generated international public health concern. 
 Differentiation of findings otherwise between regions of the study posed a puzzle.  
Although amphetamine injection was twice as common in Central Europe and Ukraine, all 
significant regional findings that amphetamine injection predicted heterosexual sex risk were in 
the Russian Federation.  
One hypothesis of this study anticipated a difference in sexual risk findings between the 
two regions that might be attributed to a protective factor of SEP participation in Central Europe 
and Ukraine.  Prior to the study, Central European and Ukrainian SEPs had been in operation for 
two to four years, dependent on the city, providing PWID communities with free, non-
judgmental safe injection and safe sex education, syringe exchange and condoms and medical 
testing (Chemical Dependency Institute, Beth Israel Medical Center, 2000).  In stark contrast, 
nearly all SEP services among drug use communities in the Russian Federation had been 
launched during or just prior to the year of this study.  However, the examination of the actual 
number of months of SEP utilization by participants did not indicate that amphetamine injectors 
who had utilized SEPs longer were less likely to engage in sexual risk. One possible explanation 
could be the inordinate discontinuity of SEP services in both regions during the year of the study 
caused by the disruption and suppression of services at two of the SEPs in Central Europe and 
Ukraine; and by an act of terrorist destruction against the oldest SEP in the Russian Federation. 
An alternative explanation for the regional differences in sex risk among amphetamine 
injectors could be that PWIDs of Central Europe and Ukraine did not inject amphetamines as 
frequently or for as long as their Russian counterparts.  Maladaptive behavioral sensitization is a 
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consequence of high dosage and long-term use of amphetamines (Fillmore, 2003; Hyman, 2005; 
McKim, 2007; Moore, 1977).  This study did not have the appropriate data to examine if 
frequency of injection or length of time of amphetamine use were factors determining the impact 
of amphetamine injection on sexual risk. The likelihood that Central European participants of the 
study were new or intermittent amphetamine injectors is unknown and is at least arguable.  
Amphetamine use by PWIDs in local communities, predominantly of the self-made type, was 
commonly reported in the years prior to the study by the SEPs in Prague, Budapest and Krakow 
(Ban, 1993; Sananim, 1998; Wodowski & Zygadlo, 1997), so that long-term amphetamine use 
among Central European participants of the study was not improbable. 
Another possible determinant of the significant regional differences in sex risk findings 
might be the potency of the different types of amphetamines that were injected by the 
participants in the study.  Study participants were asked whether they injected powder 
amphetamines or self-made, liquid amphetamines.  No clear distinction was made between 
commercially acquired (and whether imported or local commodities) and home-made crystal, 
powder and liquid products; nor between the amphetamine analogs that participants might have 
injected. At the time of this study, very little rigorous ethnographic research about drug use 
cultures had been accomplished in Central and Eastern Europe (Grund et al., 2010), limiting the 
potential of the information to be captured by the variables that were developed about 
amphetamine use for this study.  
Finally, findings of this study that suggest the existence of a subculture of preferential 
amphetamine injectors in the Russian Federation could illuminate the regional differences in 
heterosexual sex risk among amphetamine injectors.  Significantly less likely to inject opiates, 
younger and more likely to have sex than amphetamine injectors in Central Europe and Ukraine, 
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the compound risk factors that distinguished them may have engendered the combined 
psychophysical determinants of their greater risk for sexual transmission of HIV. 
Limitations 
 The original hypothesis proposed for this study was that increased amphetamine injection 
resulted in increased sexual risk.  In the course of data analysis it was found that numbers of 
responses to key variables in several cities were small, making those data insufficient for 
analyses as originally planned.  Ordinal data were consolidated as dichotomous to permit logistic 
regression analysis.  As a result, frequencies of different types of injection, sex and sex risk 
behaviors were not analyzed.  The hypothesis of the study was adjusted accordingly and a 
different hypothesis was tested.  The findings of this study are the results of examining if 
amphetamine injection predicted sexual risk.    
 Disruption of drug user communities at some study locations was particularly challenging 
to the statistical power of data.  Drug user ‘round-up” campaigns by police in Krakow and 
demoralizing operational setbacks in Budapest seriously undermined data collection goals at 
those locations.  Far fewer interviews were completed than the prescribed quota, reducing the 
power of those individual city samples.  Data collection in Budapest was protracted and 
dependent upon the halting progress of mismanaged staff at the SEP to maintain services to 
PWIDs.  SEP staff in Krakow found SEP participants increasingly distrustful of being 
questioned, particularly by unfamiliar research interviewers.  Arson of the St. Petersburg bus 
could, similarly, have exacerbated distrust among its participants.  Already members of 
vulnerable communities, the increased likelihood of bias among participants to provide default 
socially desired responses should be considered a factor of data collection.  
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On the other hand, adaptations of the method of the study may have mitigated response 
bias somewhat and should also be taken into account.  In Krakow, SEP staff was permitted to 
conduct research interviews rather than independent interviewers. The familiarity of staff among 
participants and the validation it received for its advocacy of the rights of its membership during 
fearful times, several months of which their work went unpaid, could have positively affected 
participants’ perceptions of the value of the study to their community.  Interviews in St. 
Petersburg took place seven months after the SEP vehicle was destroyed.  The perseverance of 
the SEP staff to maintain services to its membership throughout those difficult months may have 
lent validation of the study to its reception by SEP participants. 
The issue of response bias of self-reported data is a constant and important issue of 
concern for data analysis.  Regarding these data specifically, self-reports of high rates of 
potentially harmful sexual risk behaviors and formerly criminalized STI diagnoses could be 
considered evidence of participants’ efforts to report true-to-life. 
Finally, there were some limitations in the design and execution of the study. Variables 
about amphetamine use were limited in the scope to which they could be informative about the 
sexual risk behavior that they predicted in Central and Eastern Europe.  Interviewers made errors 
following skip and coding instructions and they were corrected in the process of data cleaning. 
Only those data that were validated by following skip instructions appropriately were utilized, 
resulting in the reduction of power of some analyses.   Other random errors that may have 
occurred among the hand-written notations of participants responses on hard-copy questionnaires 
cannot be known and those data would be lost.  
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Appendix of Tables 
Table 1  
Years of Operation of Syringe Exchange Programs 
 in 5 Cities of Central Europe and Ukraine 
 
Locations of Syringe Exchange Programs Years 
Prague, Czech Republic 4 
Budapest, Hungary 3 
Skopje, FYR Macedonia 3 
Krakow, Poland 3 
Poltava, Ukraine 2 
Note.  Years are measured from the start-up of syringe exchange 





Years of Operation of Syringe Exchange Programs  
in 5 Cities of the Russian Federation 
 




St. Petersburg 3 
Volgograd <1 
Note.  Years are measured from the start-up of syringe exchange 
operations to the start-up of data collection for this study.  
*The program in Pskov was one of the 4 new programs chosen for this 
study. It was the only new program in the study that launched operations 
before 1999 and it did so in August 1998 with the mentorship of the 
established program in neighboring St. Petersburg.    





Demographic Characteristics and Health Information about PWIDs 
Who Participated in Syringe Exchange in the Past 30 Days 











Characteristics M SD M SD M SD p 
        
Agea 27.0 6.4 24.9 6.3 25.9 6.3 <.0001 
        
        
 n % n % n %  
Genderb        
Male 453 76% 841 78% 1294 77%  
        
Female 142 24% 235 22% 377 23% .3 
        
Health Informationb        
        
Ever STI diagnosis 130 23% 268 25% 398 24% .3 
        
Ever had HIV testc 449 79% 837 79% 1286 79% .8 
        
Know HIV test 
resultsc,d 423 91% 759 92% 1182 92% .4 
        
Ever HIV+ test 
resulte,f 23 6% 79 11% 102 9% .01 
        
at-test procedure.   b Chi-square test procedure.   cFrequency missing includes “don’t know” and 
“refused to answer” values.  dPer cents are based on the number of participants who ever had an HIV 
test. eFrequency missing includes “indeterminate,” ”don’t know” and “refused to answer” values.  fPer 
cents are based on the number of participants who ever received an HIV test result.  





Amphetamine Injection and Opiate Injection in the Past 30 Days  
among PWIDs Who Participated in Syringe Exchange  










Injected Drug Use n % n % n % p 
        
Amphetaminesa 148 25% 205 19% 353 21% .005 
        
Opiatesb 494 90% 819 87% 1313 88% .09 
        
Opiate injection reported 
by amphetamine injectorsc 98 83% 79 41% 177 57% <.0001 
        
Note: Results based on Chi-square test procedure. Missing values were not included in totals.  
aamphetamines injectors include participants who reported any powder and/or liquid self-made amphetamine 
injection; bopiates injectors include participants who reported any heroin powder, homemade opiate or opium 







Heterosexual Penetrative Sex in the Past 30 Days Reported by PWIDs 
Who Participated in Syringe Exchange  










Penetrative Sex n % n % n % p 
        
With partners of the opposite sex 334 57% 811 78% 1145 70% <.0001 
        
among amphetamines 
injectorsa,b 88 60% 160 79% 248 71% <.0001 
        
Note: Results based on Chi-square test procedure. Missing values were not included in totals.  
aamphetamines injectors include participants who reported any powder and/or liquid self-made amphetamine injection.  
bPer cents are based on the number of participants who reported any amphetamines injection. 





Not Always Condom Use during Penetrative Sex and Amphetamine Injection 
In 5 Cities of Central Europe and Ukraine in the Past 30 Days 
Sex Partners Sex Risk 
 OR 95% CI p 
Primary partnersa    
Amphetamine injection 1.0 0.5, 2.1 1.0 
Age 1.0 0.9, 1.1 .9 
Gender 1.5 0.7, 3.1 .3 
    
Casual partnersb    
Amphetamine injection 1.6 0.6, 4.6 .4 
Age 0.9 0.9, 1.0 .07 
Genderc 0.3 0.1, 0.9 .03 
    
Note. Injected amphetamines comprise both powder and liquid forms that were reported by 
participants; OR = odds ratio; CI = confidence interval; sex risk = did not always use condoms 
when having penetrative sex; gender = male or female. Findings are results of multivariate logistic 
regression analysis. The validity of logistic regression analyses of data for “sex partner who gave 
money for sex” and for “sex partner who gave drugs for sex” was questionable; therefore, those 
findings are not reported here. 
an=227.  bn=82.  cFor data analysis in this study, gender was dichotomized so that male=0 and 











Not Always Condom Use during Penetrative Sex, Amphetamine Injection, 
and History of STIs in 5 Cities of Central Europe and Ukraine in the Past 30 Days 
Sex Partners Sex Risk 
 OR 95% CI p 
Primary partnersa    
Amphetamine injection 1.0 0.5, 2.0 .9 
Age 1.0 1.0, 1.1 .9 
Gender 1.6 0.7, 3.4 .2 
History of STIs 0.9 0.4, 1.9 .8 
    
Casual partnersb    
Amphetamine injection 1.8 0.6, 5.5 .3 
Age 0.9  0.9, 1.0 .1 
Genderc 0.3 0.1, 0.8 .02 
History of STIs 1.7 0.5, 6.5 .4 
    
Note. Injected amphetamines comprise both powder and liquid forms that were reported by 
participants; OR = odds ratio; CI = confidence interval; sex risk = did not always use condoms when 
having penetrative sex; gender = male or female. Findings are results of multivariate logistic regression 
analysis. The validity of logistic regression analyses of data for “sex partner who gave money for sex” 
and for “sex partner who gave drugs for sex” was questionable; therefore, those findings are not 
reported here.  










Not Always Condom Use during Penetrative Sex, Amphetamine Injection, 
and HIV Serostatus in 5 Cities of Central Europe and Ukraine in the Past 30 Days 
Sex Partners Sex Risk 
 OR 95% CI p 
Primary partnersa    
Amphetamine injection 1.0 0.4, 2.3 1.0 
Age 1.0 0.9, 1.1 .9 
Gender 1.7 0.7, 4.0 .3 
HIV serostatus 0.2 0.1, 1.1 .07 
    
Note. Injected amphetamines comprise both powder and liquid forms that were reported by participants; 
OR = odds ratio; CI = confidence interval; sex risk = did not always use condoms when having 
penetrative sex; gender = male or female. Findings are results of multivariate logistic regression 
analysis. The validity of logistic regression analyses of data for “casual partner,” “sex partner who gave 
money for sex” and for “sex partner who gave drugs for sex” was questionable; therefore, those findings 











Not Always Condom Use during Penetrative Sex and Amphetamine Injection 
In 5 Cities of the Russian Federation in the Past 30 Days 
Sex Partners Sex Risk 
 OR 95% CI p 
Primary partnersa    
Amphetamine injection 1.6 1.0, 2.5 .04 
Age 1.032 1.002, 1.063 .04 
Gender 1.2 0.8, 1.4 .4 
    
Casual partnersb    
Amphetamine injection 2.3 1.2, 4.4 .01 
Age 1.0 0.9, 1.0 .7 
Gender 0.7 0.4, 1.3 .2 
    
Partners who gave money for sexc    
Amphetamine injection 1.5 0.3, 7.0 .6 
Age 0.9 0.8, 1.1 .3 
Gender 0.5 0.04, 6.7 .6 
    
Partners who gave drugs for sexd    
Amphetamine injection 1.5 0.3, 9.2 .6 
Age 1.0 0.9, 1.1 1.0 
Gender 0.5 0.1, 3.2 .4 
    
Note. Injected amphetamines comprise both powder and liquid forms that were reported by participants; OR = odds 
ratio; CI = confidence interval; sex risk = did not always use condoms when having penetrative sex; gender = male or 
female. Findings are results of multivariate logistic regression analysis.  











Not Always Condom Use during Penetrative Sex, Amphetamine Injection, 
and History of STIs in 5 Cities of the Russian Federation in the Past 30 Days 
Sex Partners Sex Risk 
 OR 95% CI p 
Primary partnersa    
Amphetamine injection 1.6 1.0, 2.5 .05 
Age 1.0 1.0, 1.1 .07 
Gender 1.1 0.8, 1.7 .5 
History of STIs 1.4 0.9, 2.1 .1 
    
Casual partnersb    
Amphetamine injection 2.2 1.2, 4.3 .01 
Age 1.0 0.9, 1.0 .6 
Gender 0.6 0.3, 1.1 .1 
History of STIs 1.8 1.0, 3.2 .07 
    
Partners who gave money for sexc    
Amphetamine injection 1.0 0.2, 5.2 1.0 
Age 0.9 0.8, 1.0 .2 
Gender 0.5 0.0, 8.4 .6 
History of STIs 11.1 1.3, 98.6 .03 
    
Partners who gave drugs for sexd    
Amphetamine injection 1.4 0.2, 9.0 .7 
Age 1.0 0.9, 1.1 .9 
Gender 0.4 0.1, 3.2 .4 
History of STIs 1.4 0.2, 8.4 .7 
    
Note. Injected amphetamines comprise both powder and liquid forms that were reported by 
participants; OR = odds ratio; CI = confidence interval; sex risk = did not always use condoms 
when having penetrative sex; gender = male or female. Findings are results of multivariate 
logistic regression analysis. 
an=704. bn=226.  cn=53. dn=27. 
 






Not Always Condom Use during Penetrative Sex, Amphetamine Injection, 
and HIV Serostatus in 5 Cities of the Russian Federation in the Past 30 Days 
Sex Partners Sex Risk 
 OR 95% CI p 
Primary partnersa    
Amphetamine injection 1.6 0.9, 2.7   .08 
Age 1.0 1.0, 1.1 .01 
Gender 1.1 0.7, 1.8 .6 
HIV serostatus 0.3 0.1, 0.5 <.0001 
    
Casual partnersb    
Amphetamine injection 2.3 1.1, 5.0 .02 
Age 1.0 0.9, 1.0 .5 
Gender 0.6 0.3, 1.2 .2 
HIV serostatus 1.0 0.3, 3.0 1.0 
    
Partners who gave drugs for sexc    
Amphetamine injection 2.3 0.2, 31.0 .5 
Age 1.0 0.9, 1.2 .9 
Gender 0.6 0.1, 7.0 .7 
HIV serostatus 0.2 0.0, 6.0 .3 
    
Note. Injected amphetamines comprise both powder and liquid forms that were reported by 
participants; OR = odds ratio; CI = confidence interval;  sex risk = did not always use condoms 
when having penetrative sex; gender = male or female.  Findings are results of multivariate 
logistic regression analysis. The validity of logistic regression analyses of data for “sex partner 
who gave money for sex” was questionable; therefore, those findings are not reported here. 
an=498.  bn=153.  cn=22.   
 
 






Number of Months of SEP Utilization by Amphetamine Injectors  
and Sexual Risk in the Past 30 Days 
in 10 Cities of Central and Eastern Europe 
Sex Partners Months of SEP Utilization 
 Months (M) N p 
Primary partners   .7 
 Not always condom use  10.9 155  
 Always condom use  11.9 43  
    
Casual partners   .2 
 Not always condom use 16.6 44  
 Always condom use 10.9 33  
    
Partners who gave money for sex   .4 
 Not always condom use 4.3 3  
 Always condom use 12.1 10  
    
Note. Injected amphetamines comprise both powder and liquid forms that were reported by participants; sex 
risk = did not always use condoms when having penetrative sex. Findings are the results of one-way analysis 
of variance with Scheffe’s multiple-comparison procedure. Mean separation procedures were not carried out 
for “sex partners who gave drugs for sex” because the grouped variable had only one level: not always 
condom use. 
 
